Statistics
Publications
44
Citations
6K
H-Index
34
Active since
1987
Scott B. Berger is an author at GlaxoSmithKline (United States) specializing in life sciences, immunology, and inflammation.
Publications per year
1987–2025
44
44
Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death
Pontus Ørning, Dan Weng, Kristian K. Starheim et al. · Science · 2018 · 1.1K citations · Full text
RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
Pratyusha Mandal, Scott B. Berger, Sirika Pillay et al. · Molecular Cell · 2014 · 615 citations · Full text
Philip A. Harris, Scott B. Berger, Jae Uk Jeong et al. · Journal of Medicinal Chemistry · 2017 · 475 citations · Full text
Scott B. Berger, Viera Kasparcova, Sandy Hoffman et al. · The Journal of Immunology · 2014 · 373 citations · Full text
1–5 of 44